HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1418
https://www.valueinhealthjournal.com/article/S1098-3015(24)01533-X/fulltext
Title :
HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01533-X&doi=10.1016/j.jval.2024.03.1418
First page :
Section Title :
Open access? :
No
Section Order :
10802